Brief: LSL Pharma Announces Exclusive Distribution Agreement With Fera Pharmaceuticals To Alleviate Drug Shortage In U.S. Hospitals
18/10/2023 12:08
Oct 18 (Reuters) - LSL Pharma Group Inc LSL.V :
* LSL PHARMA GROUP ANNOUNCES EXCLUSIVE DISTRIBUTION
AGREEMENT WITH
FERA PHARMACEUTICALS TO ALLEVIATE DRUG SHORTAGE IN U.S.
HOSPITALS
* LSL PHARMA GROUP- UNDER DEAL, CO, VIA MANUFACTURING UNIT,
COULD
INITIALLY SUPPLY UP TO 25% OF 4 MILLION DOSES REQUIRED ANNUALLY
IN U.S. HOSPITAL MARKET
* LSL PHARMA GROUP INC - MORE ERYTHROMYCIN OPHTHALMIC
OINTMENT MAY
BECOME AVAILABLE IF DRUG SHORTAGE PERSISTS
Source text for Eikon: ID:nGNX5B2wvC
Further company coverage: LSL.V
((Reuters.Briefs@thomsonreuters.com))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering